Finance

Lists
002365:SHE
Qianjiang Yongan Pharmaceutical Co Ltd
CN¥12,94
-1,67%
(-0,22) 1D
13 Okt., 15:04:18 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002365...
Open
CN¥13,01
High
CN¥13,07
Low
CN¥12,52
Mkt. cap
3,88 mjd
Avg. vol.
31,72 m
Volume
14,72 m
Dividend
0,77%
Quarterly dividend
CN¥0,03
Ex-dividend date
11 Jun. 2026
P/E ratio
70,15
52-wk high
CN¥19,90
52-wk low
CN¥9,82
EPS
CN¥0,18
Shares outstanding
294,68 m
No. of employees
912
Open
CN¥13,01
High
CN¥13,07
Low
CN¥12,52
Mkt. cap
3,88 mjd
Avg. vol.
31,72 m
Volume
14,72 m
Dividend
0,77%
Quarterly dividend
CN¥0,03
Ex-dividend date
11 Jun. 2026
P/E ratio
70,15
52-wk high
CN¥19,90
52-wk low
CN¥9,82
EPS
CN¥0,18
Shares outstanding
294,68 m
No. of employees
912
News stories
From web sources and news partners
About Qianjiang Yongan Pharmaceutical Co Ltd
CEO-
Employees912
Founded18 Jun. 2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
209,77 m
206,02 m
235,90 m
327,81 m
Cost of goods sold
169,02 m
173,34 m
188,18 m
232,78 m
Cost of revenue
169,02 m
173,34 m
188,18 m
232,78 m
Research and development expenses
8,72 m
4,79 m
8,62 m
12,19 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,66 m
22,80 m
23,64 m
27,21 m
Operating expense
44,57 m
30,70 m
37,00 m
47,52 m
Total operating expenses
213,59 m
204,04 m
225,17 m
280,30 m
Operating income
-3,82 m
1,98 m
10,73 m
47,51 m
Other non operating income
1,12 m
-1,92 m
-3,03 m
2,61 m
EBT including unusual items
8,54 m
-8,14 m
9,16 m
48,78 m
EBT excluding unusual items
9,56 m
5,39 m
13,05 m
48,05 m
Income tax expense
753,52 k
1,01 m
1,17 m
13,99 m
Effective tax rate
8,82%
-12,40%
12,78%
28,67%
Other operating expenses
2,44 m
2,38 m
3,08 m
3,04 m
Net income
13,00 m
-3,00 m
7,74 m
35,67 m
Net profit margin
6,20%
-1,46%
3,28%
10,88%
Earnings per share
-
-
-
-
Interest and investment income
14,15 m
5,67 m
5,37 m
4,18 m
Interest expense
-217,73 k
-203,05 k
-10,40 k
-20,88 k
Net interest expenses
13,93 m
5,47 m
5,36 m
4,15 m
Depreciation and amortization charges
-
-
-
-
EBITDA
24,35 m
31,15 m
39,90 m
75,68 m
Gain or loss from assets sale
32,63 k
-185,68 k
-
-8,23 k
AI content may include mistakes. Learn more
Google-programme